Search

Články časopisu Nutrition in the acute phase of illness

Author of the article: František Novák Source: Vnitřní lékařství | 3/2019 4. 4. 2019

News Technology as an Aid in Home Oral Care

Good oral hygiene is a prerequisite for good health, both in the mouth area and in terms of overall condition. To make it more effective and easier, it is now possible to use technologically advanced tools that allow users to achieve and maintain high hygiene standards in regular daily care.

Source: Dental Care 22. 2. 2023

News To what extent can the actual level of ALP, ALT, or bilirubin differ from the measured value?

A physician who bases clinical decisions on laboratory-determined values of biological parameters or their changes should always consider the possible measurement deviation, which for alkaline phosphatase (ALP), alanine aminotransferase (ALT), or bilirubin can reach several percent in both positive and negative directions.

Source: Primary Biliary Cholangitis 14. 5. 2021

News Intermittent Fasting May Carry Significant Health Risks

Results from an observational study presented at this year’s American Heart Association (AHA) Congress revealed surprising findings. Eating restricted to an 8-hour window daily—a popular form of intermittent fasting—may be associated with a significantly higher risk of cardiovascular (CV) death compared to regular eating within a 12–16-hour window.

Source: 29. 10. 2024

News Lactobacillus reuteri −⁠ a natural probiotic with lifelong significance

Probiotics are often given to newborns within the first few days of life to alleviate infantile colic. However, the role of probiotic treatment in protecting infants from infections, even into their adult life, is a growing area of research interest. Which natural probiotic strains have verified immunomodulatory properties and is it suitable to administer them alongside breast milk?

Source: GI, colic and microbiome 16. 2. 2021

News Ketogenic diet in MS patients as an aid to increase microbiota diversity and quantity

A recent study published in the journal Frontiers in Microbiology explores the role of gut microbiota in multiple sclerosis, specifically the changes in its quantity and the potential for influencing microbiota through a ketogenic diet.

Source: Multiple Sclerosis 21. 2. 2020

News How and when does the reaction to gluten begin in coeliac disease? A new Canadian study offers potential answers

As is well known, coeliac disease is a systemic autoimmune disorder characterised by damage to intestinal epithelial cells (IEC). Canadian researchers have sought to uncover the relationship between intestinal epithelial cells and T lymphocyte activation in this disease. The results of their work provide hope for the potential development of an effective therapy.

Source: 6. 11. 2024

News Change in Release of Medication Pradaxa

Dear Doctor,
We would like to inform you that from April 1, 2021, based on the decision of the State Institute for Drug Control (SÚKL), the release of the medication (LP) Pradaxa (dabigatran-etexilate) 150 and 110 mg in the indication “Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation” will be changed to first-line treatment.

Source: Anticoagulant Treatment 31. 3. 2021

News Effect of 3 Different Doses of Trazodone on QT Interval Length

Patients diagnosed with depression often also suffer from cardiovascular diseases, including heart failure. Given the increased risk of death in such comorbid patients, the safety and efficacy of the antidepressant must be considered when choosing one.

Source: Depression and Anxiety 5. 10. 2020

News Gut-Brain Axis −⁠ Future of MS Treatment?

The relationship between the gut microbiome and multiple sclerosis has been a major topic recently. How far has current science progressed in decoding this issue? A recent review article published in the journal Neuroscience Research summarizes the existing findings on the relationship of the gut microbiome to the etiopathogenesis and course of multiple sclerosis (MS).

Source: Multiple Sclerosis 3. 5. 2022

News Psilocybin Approved as of January 1. What Does This Mean in Practice?

As of January 1, 2026, a new legal framework has come into effect in the Czech Republic allowing the limited therapeutic use of psilocybin in patients with severe mental health conditions. This represents the first systematic step in translating the results of long-term clinical research on psychedelics into healthcare practice. How does this change clinical practice, and what should physicians know even if they do not provide this therapy themselves?

Source: 2. 2. 2026

Články časopisu Nutrition in the acute phase of illness

News Technology as an Aid in Home Oral Care

News To what extent can the actual level of ALP, ALT, or bilirubin differ from the measured value?

News Intermittent Fasting May Carry Significant Health Risks

News Lactobacillus reuteri −⁠ a natural probiotic with lifelong significance

News Ketogenic diet in MS patients as an aid to increase microbiota diversity and quantity

News How and when does the reaction to gluten begin in coeliac disease? A new Canadian study offers potential answers

News Change in Release of Medication Pradaxa

News Effect of 3 Different Doses of Trazodone on QT Interval Length

News Gut-Brain Axis −⁠ Future of MS Treatment?

News Psilocybin Approved as of January 1. What Does This Mean in Practice?

Články časopisu How Do Courts Set Health Policy? The Case of the Colombian Constitutional Court

Články časopisu Mapping the Spread of Malaria Drug Resistance

Články časopisu Grading Quality of Evidence and Strength of Recommendations: A Perspective

Články časopisu The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States